{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:03:14Z","timestamp":1780606994772,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ygyno.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:35:29Z","timestamp":1542879329000},"page":"228-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer"],"prefix":"10.1016","volume":"152","author":[{"given":"Melissa","family":"Javellana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0941-6689","authenticated-orcid":false,"given":"Claire","family":"Hoppenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-1507","authenticated-orcid":false,"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.11.007_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0010","series-title":"Engineering, and Medicine. Ovarian Cancers: Evolving Paradigms in Research and Care","author":"National Academies of Sciences","year":"2016"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0015","series-title":"SEER Cancer Statistics Review, 1975\u20132015","author":"Howlader","year":"2018"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0025","series-title":"National Cancer Institute SEER Cancer Statistics Review 1975\u20132014","author":"Howlader","year":"2017"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","article-title":"Characteristics of long-term survivors of epithelial ovarian cancer","volume":"126","author":"Cress","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/IGC.0b013e3181991b13","article-title":"A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors","volume":"19","author":"\u00c5keson","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2016.03.010","article-title":"Characteristics of 10-year survivors of high-grade serous ovarian carcinoma","volume":"141","author":"Dao","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0050","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0055","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2017.10.032","article-title":"Who are the long-term survivors of high grade serous ovarian cancer?","volume":"148","author":"Hoppenot","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"International Journal of Gynecology and Obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2013","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2011.04.041","article-title":"The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study","volume":"122","author":"Hamilton","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0080","series-title":"Clinicopathologic Characteristics Associated with Long-term Survival in Advanced Epithelial Ovarian Cancer: An NRG Oncology\/Gynecologic Oncology Group Ancillary Data Study","author":"Hamilton","year":"2017"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0085","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.11.007_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2015.11.009","article-title":"Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status","volume":"140","author":"Kotsopoulos","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0095","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1200\/JCO.2004.04.070","article-title":"Gene expression signature with independent prognostic significance in epithelial ovarian cancer","volume":"22","author":"Spentzos","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0100","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-04-2398","article-title":"Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers","volume":"11","author":"Berchuck","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju048","article-title":"Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples","volume":"106","author":"Riester","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1078-0432.CCR-17-1621","article-title":"Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with exceptional survival in high-grade serous ovarian cancer","author":"Garsed","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.007_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","article-title":"Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer","author":"Coscia","year":"2018","journal-title":"Cell"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T10:41:12Z","timestamp":1571222472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818314045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0090825818314045"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}